ASSISTED REPRODUCTIVE TECHNOLOGY
Assisted reproductive technology (ART) are medical procedures used primarily to address infertility. It includes procedures such as in-vitro fertilization. It may include intracytoplasmic sperm injection (ICSI), cryopreservation of gametes or embryos and/or may involve the use of fertility medication.
FOLIGRAF
Foligraf (Recombinant Human Follicle stimulating Hormone, r-hFSH) is a preparation of follicle stimulating hormone produced by genetically engineered Chinese Hamster Ovary (CHO) cells. Foligraf is India's 1st indigenously researched and developed rFSH. Foligraf has clinically proven efficacy and safety profile and is free from materials of animal origin.
Category - GONADOTROPINS
Indications - Anovulation (including polycystic ovarian disease, PCOD) in women who have been unresponsive to treatment with clomiphene citrate. Stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilization (IVF), gamete intra-fallopian transfer (GIFT) and zygote intra-fallopian transfer (ZIFT).
Dosage & Administration - Please refer pack insert for further details
Presentation - 75 IU/ 150 IU
Storage - 2- 8°C
HUMOG
Humog (Human Menopausal Gonadotropin) is a hormone containing FSH and LH in a ratio 1:1. In females, it stimulates both the growth and the maturation of follicles. In males, Humog stimulates the spermatogenesis by acting on the production of the androgen–binding protein in the seminiferous tubules of the Sertoli cells.
Category - GONADOTROPINS
Indications - Woman : Indicated for the induction of ovulation in the amenorrhoeic patient or anovulatory women with regular or irregular cycles. Men : indicated for the stimulation of spermatogenesis in men who have primary or secondary Hypogonadotrophic hypogonadism.
Dosage & Administration - Please refer pack insert for further details
Presentation - 75 IU/ 150 IU
Storage - 2- 8°C
FOLICULIN
Foliculin contains a purified hormone urofollitropin, obtained from Human Menopausal urine having 75 I.U. / 150 I.U. FSH activity and less than 1 I.U. / 2 I.U. Luteinizing Hormone activity per vial. FSH stimulates both the growth and maturation of follicles, it induces secretion of oestrogens and proliferation of the endometrium.
Category - GONADOTROPINS
Indications - Induction of ovulation in patients with Polycystic Ovarian Disease (PCOD) who have an elevated LH / FSH ratio and who have failed to respond to adequate clomiphene citrate therepy. Stimulate the development of multiple oocytes in ovulatory patients participating in an in vivo fertility program
Dosage & Administration - Please refer pack insert for further details
Presentation - 75 IU/ 150 IU
Storage - 2- 8°C
HUMOG HP
HUMOG HP is a highly Purified Human Menopausal Gonadotropin. This product is purified by High tech chromatography methods which leads a highly purified gonadotropin ensuring batch to batch consistency and potency
Category - GONADOTROPINS
Indications - Woman : Indicated for the induction of ovulation in the amenorrhoeic patient or anovulatory women with regular or irregular cycles. Men : indicated for the stimulation of spermatogenesis in men who have primary or secondary Hypogonadotrophic hypogonadism
Dosage & Administration - Please refer pack insert for further details
Presentation - 75 IU/ 150 IU
Storage - 2- 8°C
FOLICULIN HP
FOLICULIN HP contains a purified hormone urofollitropin obtained from Human Menopausal urine having FSH activity of 75 I.U. / 150 I.U. and less than 1 I.U. / 2 I.U. contains a purified hormone urofollitropin, obtained from Human Menopausal urine having FSH activity of 75 I.U. / 150 I.U. and less than 1 I.U. / 2 I.U. Luteinizing Hormone activity per vial. Human menopausal gonadotrophins (HMG) exerts both FSH and LH activities. For this reason, HMG is indicated in Hypogonadotropic hypopituitarism (WHO Group I patients), where both gonadotrophin stimulations are needed.
Category - GONADOTROPINS
Indications
a) Induction of ovulation in PCOD Patients
b) Stimulate the development of multiple oocytes in ovulatory patients participating in an in vivo fertility program
Dosage & Administration - Please refer pack insert for further details
Presentation - 75 IU/ 150 IU
Storage - 2- 8°C
ASPORELIX
Cetrorelix acetate is a synthetic decapeptide with gonadotropin releasing hormone (GnRH) antagonist activity.
Category - Gonadotropin releasing hormone (GnRH) antagonist.
Dosage & Administration - Please refer pack insert for further details
Presentation - Vial Containing 0.25 mg lyophilised powder for injection of Cetrorelix acetate, along with ampoule containing 1ml of sterile water for injection IP as diluent.
Storage - 2- 8°C
R-HUCOG
r-HUCOG is composed of a non-pyrogenic solution of recombinant human chorionic gonadotrophin (r-HUCOG ), a water-soluble glycoprotein consisting of two non-covalently linked subunits, consisting of 92 and 145 amino acid residues. The drug substance is produced by recombinant DNAtechniques. Its structure and glycosylation pattern are very similar to that of urinary hCG.
Category - Recombinant Human Chorionic Gonadotrophin
Indications -
r-HUCOG® is indicated in the treatment of:
1. Women undergoing superovulation prior to assisted reproductive techniques (ART) such as in vitro fertilization (IVF) :
r-HUCOG® is administered to trigger final follicular maturation and luteinisation after stimulation of follicular growth.
2. Anovulatory/ oligo-ovulatory women: r-HUCOG® in the treatment of anovulatory infertility where its administration is used would form part of recognized treatment regimen involving the prior stimulation of follicular maturation and endometrial proliferation.
Dosage & Administration - Please refer pack insert for further details
Presentation - Recombinant Human Chorionic Gonadotrophin 6500 I.U.*, Water for Injection I.P q.s. Histidine, Glycine, Sucrose, Methionine, and Polysorbate 20. *250 µg is not less than 6500 I.U.
Storage - Store between 2°C -8°C. Do not freeze.